The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Adverum Biotechnologies, Inc. | Common | 00773U108 | 1,454 | 134,154 | SH | SOLE | 134,154 | 0 | 0 | ||
Antero Resources LLC | Common | 03674X106 | 719 | 131,895 | SH | SOLE | 131,895 | 0 | 0 | ||
Castlight Health, Inc. | Common CLB | 14862Q100 | 454 | 349,070 | SH | SOLE | 349,070 | 0 | 0 | ||
Cytomx Therapeutics, Inc. | Common | 23284F105 | 519 | 79,193 | SH | SOLE | 79,193 | 0 | 0 | ||
Exagen, Inc. | Common | 30068X103 | 343 | 25,982 | SH | SOLE | 25,982 | 0 | 0 | ||
Epizyme, Inc. | Common | 29428V104 | 268 | 24,686 | SH | SOLE | 24,686 | 0 | 0 | ||
Hallador Energy Resources, Inc. | Common | 40609P105 | 21 | 14,270 | SH | SOLE | 14,270 | 0 | 0 | ||
LendingClub Corp. | Common | 52603A208 | 5,422 | 513,440 | SH | SOLE | 513,440 | 0 | 0 | ||
NextCure, Inc. | Common | 65343E108 | 109 | 10,044 | SH | SOLE | 10,044 | 0 | 0 | ||
Progyny, Inc. | Common | 74340E103 | 1,261 | 29,743 | SH | SOLE | 29,743 | 0 | 0 | ||
Ramaco Resources, Inc. | Common | 75134P303 | 43 | 14,951 | SH | SOLE | 14,951 | 0 | 0 | ||
Rapt Therapeutics, Inc. | Common | 75382E909 | 244 | 12,351 | SH | SOLE | 12,351 | 0 | 0 | ||
Seres Therapeutics, Inc. | Common | 81750R102 | 2,056 | 83,903 | SH | SOLE | 83,903 | 0 | 0 | ||
Slack Technologies, Inc. | Common CL A | 83088V102 | 2,578 | 61,037 | SH | SOLE | 61,037 | 0 | 0 | ||
Spark Networks SE | Sponsored ADR | 846517100 | 2,674 | 502,576 | SH | SOLE | 502,576 | 0 | 0 | ||
TelaDoc Health, Inc. | Common | 87918A105 | 10,187 | 50,943 | SH | SOLE | 50,943 | 0 | 0 | ||
Trevena, Inc. | Common | 89532E109 | 500 | 233,850 | SH | SOLE | 233,850 | 0 | 0 | ||
Yumanity | Common | 98872L102 | 375 | 22,030 | SH | SOLE | 22,030 | 0 | 0 | ||
Yext, Inc. | Common | 98585N106 | 1,810 | 115,147 | SH | SOLE | 115,147 | 0 | 0 | ||
Zuora, Inc. | Common | 98983V106 | 2,283 | 163,894 | SH | SOLE | 163,894 | 0 | 0 | ||
Axcella Health, Inc. | Common | 05454B105 | 14,573 | 2,807,981 | SH | SOLE | 2,807,981 | 0 | 0 | ||
Evelo Biosciences, Inc. | Common | 299734103 | 37,038 | 3,063,505 | SH | SOLE | 3,063,505 | 0 | 0 | ||
Rubius Therapeutics, Inc. | Common | 78116T103 | 7,490 | 986,878 | SH | SOLE | 986,878 | 0 | 0 | ||
Kaleido BioSciences, Inc. | Common | 483347100 | 16,688 | 1,833,832 | SH | SOLE | 1,833,832 | 0 | 0 | ||
Sigilon Therapeutics, Inc. | Common | 82657L107 | 35,578 | 740,740 | SH | SOLE | 740,740 | 0 | 0 | ||
Solarwinds Corp. | Common | 83417Q105 | 111,216 | 7,439,200 | SH | SOLE | 7,439,200 | 0 | 0 |